Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Pathol Res Pract ; 253: 155056, 2024 Jan.
Article in English | MEDLINE | ID: mdl-38183817

ABSTRACT

In addition to its highly aggressive nature and late diagnosis, hepatocellular carcinoma (HCC) does not respond effectively to available chemotherapeutic agents. The search is on for an ideal and effective compound with low cost and minimal side effects that can be used as an adjunct to chemotherapeutic regimens. One of the mechanisms involved in the pathology of HCC is the oxidative stress, which plays a critical role in tumor survival and dissemination. Our group has already demonstrated the antitumor potential of melatonin against HuH 7.5 cells. In the present study, we focused on the effects of melatonin on oxidative stress parameters and their consequences on cell metabolism. HuH 7.5 cells were treated with 2 and 4 mM of melatonin for 24 and 48 h. Oxidative stress biomarkers, antioxidant enzyme, mitochondrial membrane potential, formation of lipid bodies and autophagic vacuoles, cell cycle progression, cell death rate and ultrastructural cell alterations were evaluated. The treatment with melatonin increased oxidative stress biomarkers and reduced antioxidant enzyme activities of HuH 7.5 cells. Additionally, melatonin treatment damaged the mitochondrial membrane and increased lipid bodies and autophagic vacuole formation. Melatonin triggered cell cycle arrest and induced cell death by apoptosis. Our results indicate that the treatment of HuH 7.5 cells with melatonin impaired antioxidant defense systems, inhibited cell cycle progression, and caused metabolic stress, culminating in tumor cell death.


Subject(s)
Carcinoma, Hepatocellular , Liver Neoplasms , Melatonin , Humans , Carcinoma, Hepatocellular/pathology , Melatonin/pharmacology , Melatonin/therapeutic use , Antioxidants/therapeutic use , Liver Neoplasms/pathology , Oxidative Stress , Biomarkers/metabolism , Apoptosis
2.
Drug Dev Res ; 82(2): 230-240, 2021 04.
Article in English | MEDLINE | ID: mdl-32996619

ABSTRACT

In this article, a series of 29 new pyrimidine N-acylhydrazone hybrids were synthesized and evaluated in vitro against Leishmania amazonensis and Trypanosoma cruzi protozoa that cause the neglected diseases cutaneous leishmaniasis and Chagas disease, respectively. Eight of the target compounds showed significant antiprotozoal activities with IC50 values in 4.3-33.6 µM range. The more active compound 4f exhibited selectivity index greater than 15 and drug-like properties based on Lipinski's rule.


Subject(s)
Antiparasitic Agents/pharmacology , Hydrazones/pharmacology , Leishmania braziliensis/drug effects , Pyrimidines/pharmacology , Trypanosoma cruzi/drug effects , Animals , Antiparasitic Agents/chemistry , Humans , Hydrazones/chemistry , Leishmania braziliensis/physiology , Pyrimidines/chemistry , Trypanosoma cruzi/physiology
3.
Bioorg Med Chem ; 28(12): 115549, 2020 06 15.
Article in English | MEDLINE | ID: mdl-32503692

ABSTRACT

The inflammatory response is the reaction of living tissue to an injury of a foreign nature, such as infection and irritants, and occurs as part of the body's natural defence response. Compounds capable of inhibiting cyclooxygenase (COX) enzymes, especially COX-2, have great potential as anti-inflammatory agents. Herein we present the regioselective synthesis of 49 novel compounds based on the 2-pyridone nucleus. The topical anti-inflammatory activity of seventeen compounds was evaluated in mice by croton oil (CO) induced ear edema assay. Most of the compounds exhibited a high level of in vivo anti-inflammatory activity, reducing ear edema and myeloperoxidase (MPO) activity. The most active compounds (2a and 7a) were inhibitors of COX enzymes. Compound 2a selectively inhibited the COX-2, while 7a was nonselective. Further, the compound 2a showed effective binding at the active site of COX-2 co-crystal by docking molecular study.


Subject(s)
Anti-Inflammatory Agents/chemical synthesis , Pyridones/chemistry , Animals , Anti-Inflammatory Agents/metabolism , Anti-Inflammatory Agents/pharmacology , Anti-Inflammatory Agents/therapeutic use , Binding Sites , Catalytic Domain , Cell Line , Cell Survival/drug effects , Cyclooxygenase 2/chemistry , Cyclooxygenase 2/metabolism , Cyclooxygenase 2 Inhibitors/chemical synthesis , Cyclooxygenase 2 Inhibitors/metabolism , Cyclooxygenase 2 Inhibitors/pharmacology , Cyclooxygenase 2 Inhibitors/therapeutic use , Edema/chemically induced , Edema/drug therapy , Humans , Mice , Molecular Conformation , Molecular Docking Simulation , Peroxidase/metabolism , Pyridones/metabolism , Pyridones/therapeutic use , Stereoisomerism , Structure-Activity Relationship
SELECTION OF CITATIONS
SEARCH DETAIL
...